The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(2-((4-(4-(12-(2-((3r,5r,7r)-Adamantan-1-yl)-N-(prop-2-yn-1-yl)acetamido)dodecyl)piperazin-1-yl)-2-methoxyphenyl)amino)-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8(7H)-yl)phenyl)cyclopropanecarboxamide ID: ALA5171045
PubChem CID: 168269868
Max Phase: Preclinical
Molecular Formula: C56H74N8O4
Molecular Weight: 923.26
Associated Items:
Names and Identifiers Canonical SMILES: C#CCN(CCCCCCCCCCCCN1CCN(c2ccc(Nc3ncc4c(C)cc(=O)n(-c5cccc(NC(=O)C6CC6)c5)c4n3)c(OC)c2)CC1)C(=O)CC12CC3CC(CC(C3)C1)C2
Standard InChI: InChI=1S/C56H74N8O4/c1-4-22-63(52(66)38-56-35-41-30-42(36-56)32-43(31-41)37-56)24-14-12-10-8-6-5-7-9-11-13-23-61-25-27-62(28-26-61)46-20-21-49(50(34-46)68-3)59-55-57-39-48-40(2)29-51(65)64(53(48)60-55)47-17-15-16-45(33-47)58-54(67)44-18-19-44/h1,15-17,20-21,29,33-34,39,41-44H,5-14,18-19,22-28,30-32,35-38H2,2-3H3,(H,58,67)(H,57,59,60)
Standard InChI Key: SLGFJMFVVYIJPT-UHFFFAOYSA-N
Molfile:
RDKit 2D
68 76 0 0 0 0 0 0 0 0999 V2000
-7.8749 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8749 -0.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1678 -0.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4312 -0.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7240 -0.5598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7240 0.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0169 0.6776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.3098 0.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3098 -0.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0169 -0.9722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.0169 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5732 -0.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8661 -0.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1589 -0.9722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1589 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4518 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 -1.7972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0082 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6989 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4060 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1426 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8497 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5568 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2640 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0006 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7077 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4148 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1219 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8585 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5656 -2.2097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5656 -3.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2727 -3.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9799 -3.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2727 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9799 -2.2097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2727 -0.9722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7153 -0.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4518 -0.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8661 0.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5732 0.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4312 0.6776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.1678 0.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8749 0.6776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.8749 1.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1678 1.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1678 2.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8749 3.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5820 2.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2891 3.1525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.0257 2.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.7328 3.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1453 3.8596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.5578 3.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.0257 1.9151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.5820 1.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5820 0.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5820 -0.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2891 0.6776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7069 -2.4600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7165 -1.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2134 -1.5957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5159 -1.1426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5578 -1.7589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0202 -1.9592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6161 -1.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5903 -0.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3377 -1.3815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1259 -0.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 3 0
30 34 1 0
34 35 1 0
34 36 2 0
17 37 1 0
37 38 1 0
14 38 1 0
13 39 1 0
39 40 2 0
8 40 1 0
6 41 1 0
41 42 2 0
3 42 1 0
42 43 1 0
43 44 1 0
44 45 2 0
45 46 1 0
46 47 2 0
47 48 1 0
48 49 1 0
49 50 1 0
50 51 1 0
51 52 1 0
52 53 1 0
51 53 1 0
50 54 2 0
48 55 2 0
44 55 1 0
43 56 1 0
2 57 2 0
57 56 1 0
56 58 2 0
59 60 1 0
60 35 1 0
60 61 1 0
61 62 1 0
63 62 1 0
64 63 1 0
59 64 1 0
64 65 1 0
65 66 1 0
66 67 1 0
60 67 1 0
68 66 1 0
62 68 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 923.26Molecular Weight (Monoisotopic): 922.5833AlogP: 10.28#Rotatable Bonds: 23Polar Surface Area: 124.93Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 3CX Acidic pKa: 13.53CX Basic pKa: 8.49CX LogP: 10.17CX LogD: 9.05Aromatic Rings: 4Heavy Atoms: 68QED Weighted: 0.06Np Likeness Score: -1.31
References 1. Xu F, Zhang X, Chen Z, He S, Guo J, Yu L, Wang Y, Hou C, Ai-Furas H, Zheng Z, Smaill JB, Patterson AV, Zhang ZM, Chen L, Ren X, Ding K.. (2022) Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells., 65 (20.0): [PMID:36173763 ] [10.1021/acs.jmedchem.2c01246 ]